Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Johnson & Johnson (JNJ)

Add to Watchlists
Create an Alert
100.20 +0.02  +0.02% NYSE Apr 23, 3:35PM BATS Real time Currency in USD

Johnson & Johnson Research and Development Expense (Quarterly):

1.831B for March 31, 2014

View 4,000+ financial data types

View Full Chart

Johnson & Johnson Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Johnson & Johnson Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
March 31, 2014 1.831B
Dec. 31, 2013 2.411B
Sept. 30, 2013 2.042B
June 30, 2013 1.946B
March 31, 2013 1.784B
Dec. 31, 2012 2.331B
Sept. 30, 2012 1.923B
June 30, 2012 1.766B
March 31, 2012 1.645B
Dec. 31, 2011 2.155B
Sept. 30, 2011 1.773B
June 30, 2011 1.882B
March 31, 2011 1.738B
Dec. 31, 2010 1.982B
Sept. 30, 2010 1.657B
June 30, 2010 1.648B
March 31, 2010 1.557B
Dec. 31, 2009 2.213B
Sept. 30, 2009 1.617B
June 30, 2009 1.638B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
   
Dec. 31, 2007 Upgrade
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

JNJ Research and Development Expense (Quarterly) Benchmarks

Companies
Merck 1.835B
AbbVie 846.00M
GlaxoSmithKline 1.764B

JNJ Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 1.557B Mar 2010
Maximum 2.411B Dec 2013
Average 1.877B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.